HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Porcine endogenous retrovirus-A/C: biochemical properties of its integrase and susceptibility to raltegravir.

Abstract
Porcine endogenous retroviruses (PERVs) are present in the genomes of pig cells. The PERV-A/C recombinant virus can infect human cells and is a major risk of zoonotic disease in the case of xenotransplantation of pig organs to humans. Raltegravir (RAL) is a viral integrase (IN) inhibitor used in highly active antiretroviral treatment. In the present study, we explored the potential use of RAL against PERV-A/C. We report (i) a three-dimensional model of the PERV-A/C intasome complexed with RAL, (ii) the sensitivity of PERV-A/C IN to RAL in vitro and (iii) the sensitivity of a PERV-A/C-IRES-GFP recombinant virus to RAL in cellulo. We demonstrated that RAL is a potent inhibitor against PERV-A/C IN and PERV-A/C replication with IC50s in the nanomolar range. To date, the use of retroviral inhibitors remains the only way to control the risk of zoonotic PERV infection during pig-to-human xenotransplantation.
AuthorsAntonin Demange, Halima Yajjou-Hamalian, Kathy Gallay, Catherine Luengo, Véronique Beven, Aurélie Leroux, Marie-Pierre Confort, Elsy Al Andary, Patrice Gouet, Karen Moreau, Corinne Ronfort, Yannick Blanchard
JournalThe Journal of general virology (J Gen Virol) Vol. 96 Issue 10 Pg. 3124-3130 (Oct 2015) ISSN: 1465-2099 [Electronic] England
PMID26296914 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Raltegravir Potassium
  • Integrases
Topics
  • Animals
  • Antiviral Agents (chemistry, pharmacology)
  • Crystallography, X-Ray
  • Endogenous Retroviruses (drug effects, enzymology, physiology)
  • Inhibitory Concentration 50
  • Integrases (analysis, chemistry)
  • Protein Binding
  • Protein Conformation
  • Raltegravir Potassium (chemistry, pharmacology)
  • Swine
  • Virus Integration (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: